| RS155370 |
TMEM132D
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS1553700581 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553700597 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553700642 |
SETD2
|
Health Risk |
Pathogenic |
— |
| RS1553700656 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553700699 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Brugada syndrome |
| RS1553701033 |
FLNB
|
Health Risk |
Likely pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS1553701477 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553702006 |
MITF
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 2A, Tietz syndrome |
| RS1553702406 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553702928 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553703015 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553703211 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553703310 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1553703612 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553703619 |
MITF
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1553703909 |
FLNB
|
Health Risk |
Likely pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS1553704086 |
MITF
|
Health Risk |
Likely pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS1553704093 |
MITF
|
Health Risk |
Pathogenic |
— |
| RS1553704097 |
MITF
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 2A, Tietz syndrome |
| RS1553704183 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Sick sinus syndrome 1, Cardiac arrhythmia |
| RS1553704259 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1553704327 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS1553704446 |
FLNB
|
Health Risk |
Pathogenic/Likely pathogenic |
Larsen syndrome, Abnormality of the skeletal system |
| RS1553704489 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553704675 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Cardiovascular phenotype |
| RS1553704677 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Brugada syndrome 1 |
| RS1553704696 |
TRIP12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553704814 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Coloboma |
| RS1553704841 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553704850 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553704878 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553704896 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553704898 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553705079 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553705282 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS1553705557 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553705586 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Cardiovascular phenotype |
| RS1553706324 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553706775 |
DHX30
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with severe motor impairment and absent language, Neurodevelopmental disorder with severe motor impairment and absent language |
| RS1553706799 |
DHX30
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with severe motor impairment and absent language, Inborn genetic diseases |
| RS1553706971 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553707019 |
DHX30
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with severe motor impairment and absent language, Neurodevelopmental disorder with severe motor impairment and absent language |
| RS1553707780 |
TTN
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Cardiomyopathy |
| RS1553709380 |
ATP6V1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy 93 |
| RS1553709855 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS1553709881 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Cerebellar vermis hypoplasia |
| RS1553709907 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1553709919 |
FOXP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553710664 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS1553710694 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS1553710982 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553711195 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1553711564 |
IQCB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553712110 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553712148 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553712292 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553713075 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1553713128 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1553713167 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1553713200 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1553713469 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS1553715351 |
HGD
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkaptonuria, Alkaptonuria |
| RS1553715579 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553715636 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553715895 |
HYAL2
|
Health Risk |
Likely pathogenic |
HYAL2 deficiency, Muggenthaler-Chowdhury-Chioza syndrome |
| RS1553715911 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553716439 |
HYAL2
|
Health Risk |
Pathogenic |
HYAL2 deficiency, Muggenthaler-Chowdhury-Chioza syndrome |
| RS1553716979 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS1553717306 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553717936 |
HGD
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkaptonuria, Alkaptonuria |
| RS1553718863 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1553718908 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553718964 |
ADCY5
|
Health Risk |
Pathogenic |
— |
| RS1553721106 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553721236 |
SEC61A1
|
Health Risk |
Likely pathogenic |
Decreased circulating immunoglobulin concentration, Immunodeficiency |
| RS1553721599 |
HGD
|
Health Risk |
Likely pathogenic |
— |
| RS1553721650 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS1553722294 |
STAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS1553722309 |
STAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS1553722736 |
IQCB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1553724533 |
ANO10
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS1553724606 |
ADCY5
|
Health Risk |
Pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1553725355 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553725815 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553726054 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1553726252 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553727865 |
STAG1
|
Health Risk |
Likely pathogenic |
STAG1-related disorder, STAG1-related disorder |
| RS1553728634 |
STAG1
|
Health Risk |
Likely pathogenic |
STAG1-related disorder, STAG1-related disorder |
| RS1553729881 |
CACNA2D2
|
Health Risk |
Likely pathogenic |
— |
| RS1553730120 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553730872 |
TBC1D23
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS1553730885 |
TBC1D23
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS1553730947 |
ACAD9
|
Health Risk |
Likely pathogenic |
— |
| RS1553731603 |
TBC1D23
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS1553731605 |
TBC1D23
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS1553731681 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Familial hypocalciuric hypercalcemia |
| RS1553732126 |
ADCY5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553734044 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS1553738605 |
QRICH1
|
Health Risk |
Pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |